News
This ambitious roadmap, underpinned by delivery timelines beyond 2030, shows that UK Government is serious in its ambition to ...
14h
Sarepta Therapeutics, Inc. ( NASDAQ: SRPT) Strategic Restructure and ELEVIDYS Label Update Conference Call July 16, 2025 4:30 PM ET Douglas S. Ingram - President, CEO & Director Ian Estepan - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback